BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND IKZF1, LyF-1, 10320, ENSG00000185811, Q13422, Hs_54452, hIk-1, ZNFN1A1, IKAROS AND Treatment
8 results:

  • 1. Detection of methylated BCAT1 and ikzf1 after curative-intent treatment as a prognostic indicator for colorectal cancer recurrence.
    Pedersen SK; Symonds EL; Roy AC; Cornthwaite KJ; LaPointe LC; Young GP
    Cancer Med; 2023 Jan; 12(2):1319-1329. PubMed ID: 35822405
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Detection of recurrent colorectal cancer with high specificity using a reporting threshold for circulating tumor DNA methylated in BCAT1 and ikzf1.
    Pedersen SK; Musher BL; LaPointe LC; Tuck MK; Symonds EL; Loayza N; Young GP
    Cancer; 2022 May; 128(10):1921-1928. PubMed ID: 35290664
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Assessment of tumor burden and response to therapy in patients with colorectal cancer using a quantitative ctDNA test for methylated BCAT1/ikzf1.
    Symonds EL; Pedersen SK; Yeo B; Al Naji H; Byrne SE; Roy A; Young GP
    Mol Oncol; 2022 May; 16(10):2031-2041. PubMed ID: 35000264
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Evaluation of Circulating Tumor DNA for Methylated
    Musher BL; Melson JE; Amato G; Chan D; Hill M; Khan I; Kochuparambil ST; Lyons SE; Orsini J; Pedersen SK; Robb B; Saltzman J; Silinsky J; Gaur S; Tuck MK; LaPointe LC; Young GP
    Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2702-2709. PubMed ID: 32958500
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Genomic signatures reveal DNA damage response deficiency in colorectal cancer brain metastases.
    Sun J; Wang C; Zhang Y; Xu L; Fang W; Zhu Y; Zheng Y; Chen X; Xie X; Hu X; Hu W; Zheng J; Li P; Yu J; Mei Z; Cai X; Wang B; Hu Z; Shu Y; Shen H; Gu Y
    Nat Commun; 2019 Jul; 10(1):3190. PubMed ID: 31320627
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Circulating tumour DNA for monitoring colorectal cancer-a prospective cohort study to assess relationship to tissue methylation, cancer characteristics and surgical resection.
    Symonds EL; Pedersen SK; Murray DH; Jedi M; Byrne SE; Rabbitt P; Baker RT; Bastin D; Young GP
    Clin Epigenetics; 2018; 10():63. PubMed ID: 29796114
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A cross-sectional study comparing a blood test for methylated BCAT1 and ikzf1 tumor-derived DNA with CEA for detection of recurrent colorectal cancer.
    Young GP; Pedersen SK; Mansfield S; Murray DH; Baker RT; Rabbitt P; Byrne S; Bambacas L; Hollington P; Symonds EL
    Cancer Med; 2016 Oct; 5(10):2763-2772. PubMed ID: 27726312
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A panel of genes methylated with high frequency in colorectal cancer.
    Mitchell SM; Ross JP; Drew HR; Ho T; Brown GS; Saunders NF; Duesing KR; Buckley MJ; Dunne R; Beetson I; Rand KN; McEvoy A; Thomas ML; Baker RT; Wattchow DA; Young GP; Lockett TJ; Pedersen SK; Lapointe LC; Molloy PL
    BMC Cancer; 2014 Jan; 14():54. PubMed ID: 24485021
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.